Should a pooled analysis of FDA trials be considered representative for a population?
- PMID: 34494679
- DOI: 10.1111/opo.12884
Should a pooled analysis of FDA trials be considered representative for a population?
Comment in
-
Author's reply.Ophthalmic Physiol Opt. 2021 Nov;41(6):1387-1388. doi: 10.1111/opo.12883. Epub 2021 Sep 8. Ophthalmic Physiol Opt. 2021. PMID: 34496077 No abstract available.
Comment on
-
The risk of vision loss in contact lens wear and following LASIK.Ophthalmic Physiol Opt. 2020 Mar;40(2):241-248. doi: 10.1111/opo.12663. Epub 2020 Jan 9. Ophthalmic Physiol Opt. 2020. PMID: 31916275 Review.
References
REFERENCES
-
- Wu YT-Y, Ho A, Naduvilath T, et al. The risk of vision loss in contact lens wear and following LASIK. Ophthalmic Physiol Opt 2020;40:241-248.
-
- Sandoval HP, Donnenfeld ED, Kohnen T, et al. Modern laser in situ keratomileusis outcomes. J Cataract Refract Surg 2016;42:1224-1234.
-
- Kanclerz P, Przewłócka K. Internet as a main source of information before corneal refractive surgery. J Cataract Refract Surg 2021;47:413-414.
-
- Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and satisfaction of patients in the patient-reported outcomes with laser in situ keratomileusis (PROWL) studies. JAMA Ophthalmol 2017;135:13-22.
-
- Schallhorn JM, Schallhorn SC, Teenan D, et al. Incidence of intraoperative and early postoperative adverse events in a large cohort of consecutive laser vision correction treatments. Am J Ophthalmol 2020;210:97-106.
Publication types
LinkOut - more resources
Full Text Sources